Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Intravenous BNZ132-1-40 in Pts w/ LGL Leukemia or Refractory Cutaneous T-Cell Lymphoma

Protocol: OSU-17273

Full Title

A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients with Large Granular Lymphocyte Leukemia or Refractory Cutaneous T-Cell Lymphoma

Leukemia Lymphoma Cutaneous Lymphoma